Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer reports on weekly rhGh injection

July 11, 2006

AEterna Zentaris report on novel peptidomimetic GnRH antagonist

July 11, 2006

Ipsen report on new analogues of human MSH for obesity

July 10, 2006

Gestiva NDA accepted for filing

July 10, 2006

Preclinical update on the insulin-like effect of BFOV

July 10, 2006

BN-83152, an MC4R antagonist with potential for anorexia/cachexia-related syndromes

July 10, 2006

D-003 and policosanol compared in patients with hypercholesterolemia

July 10, 2006

Valera files for approval of Supprelin-LA in central precocious puberty

July 7, 2006

ISIS-301012 q.o.w. reduces LDL-C and apoB in subjects with mild hypercholesterolemia

July 7, 2006

Abbott and AstraZeneca to develop fibrate and statin combination treatment

July 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...